You are here

Prescription: Washington

Brand-Name Generic Deals Face End of the Line

Congress Likely to Ban Exclusion Payments
Stephen Barlas
PDF version: 
Stephen Barlas discusses ­possible legislation that might limit the ability of brand-name drug companies to delay the introduction of generic competitors.